News

On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.

Professors Gabrieli, Gubar, Martin, and Sass are honored for exceptional undergraduate teaching.

How Elissa Gibson ’22 connected the dots to form her own unique constellation of MIT experiences.

MIT researchers uncover the structural properties and dynamics of deep classifiers, offering novel explanations for optimization, generalization, and approximation in deep networks.

The program leverages MIT’s research expertise and Takeda’s industrial know-how for research in artificial intelligence and medicine.

Seven postdocs and research scientists honored for contributions to the Institute.

Ev Fedorenko’s Interesting Brains Project highlights the human brain’s remarkable capacity to adapt, reorganize in the face of early damage.

A new tool brings the benefits of AI programming to a much broader class of problems.

Study reveals key cell structures and gene expression changes near amyloid plaques and tau tangles in mouse brain tissue.

First detailed mapping and modeling of thalamus inputs onto visual cortex neurons show brain leverages “wisdom of the crowd” to process sensory information.